Emerging therapeutic uses for cannabinoids: a basic science, pharmaceutical and policy perspective

258.5K

views

38

authors

13

articles

Editors

2

Rukiyah Van Dross-Anderson

Brody School of Medicine, East Carolina University

Allyn C Howlett

School of Medicine, Wake Forest University

Impact

About

The aim of this Research Topic is to provide an analysis of emerging and clinically approved cannabinoid therapeutics. The prototypic cannabinoid is ?9-tetrahydrocannabinol (?9-THC), the primary active constituent in marijuana. Research has been underway for several decades to understand the effects of cannabinoids and to explore its therapeutic potential. This Topic will examine the use of cannabinoids for treatment of neurological, immunological, oncologic, cardiovascular and other conditions. Works will survey and analyze current knowledge of pharmacological development of phytocannabinoids, endocannabinoids, synthetic cannabinoids, and cannabinoid metabolites. These areas of research will be addressed from a basic science and pharmaceutical perspective. Furthermore, potential regulatory issues and the impact of marijuana legalization on the development of therapeutic cannabinoids will be addressed.

Original articles, literature reviews and commentaries are sought that will evaluate the most recent and relevant findings in the field of cannabinoid therapeutics. This Research Topic is intended to provide the scientific community and the public with a useful and timely view of the progress and challenges associated with development of these agents.

The aim of this Research Topic is to provide an analysis of emerging and clinically approved cannabinoid therapeutics. The prototypic cannabinoid is ?9-tetrahydrocannabinol (?9-THC), the primary active constituent in marijuana. Research has been underway for several decades to understand the effects of cannabinoids and to explore its therapeutic potential. This Topic will examine the use of cannabinoids for treatment of neurological, immunological, oncologic, cardiovascular and other conditions. Works will survey and analyze current knowledge of pharmacological development of phytocannabinoids, endocannabinoids, synthetic cannabinoids, and cannabinoid metabolites. These areas of research will be addressed from a basic science and pharmaceutical perspective. Furthermore, potential regulatory issues and the impact of marijuana legalization on the development of therapeutic cannabinoids will be addressed.

Original articles, literature reviews and commentaries are sought that will evaluate the most recent and relevant findings in the field of cannabinoid therapeutics. This Research Topic is intended to provide the scientific community and the public with a useful and timely view of the progress and challenges associated with development of these agents.

Share

Editors

Rukiyah Van Dross-Anderson

Brody School of Medicine, East Carolina University

Allyn C Howlett

School of Medicine, Wake Forest University

Impact

258,507 Total views

226,423 Article views

28,262 Article downloads

3,822 Topic views

Published In

Journal Thumbnail

Frontiers in Pharmacology

Experimental Pharmacology and Drug Discovery

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic